Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ASP-based Reimbursement For Radiopharmaceuticals Gets PhRMA Support

Executive Summary

The Pharmaceutical Research and Manufacturers of America expressed support for using an average sales price-based approach to reimbursing radiopharmaceuticals under Medicare in response to CMS' statement of its willingness to consider switching from reimbursement based on individual hospitals' claims

You may also be interested in...

Zevalin On Track For Medicare ASP-Based Reimbursement In 2010

Change to average sales price based payment for Cell Therapeutics’ radioimmunotherapy could help boost use in community oncology centers.

CMS Open To ASPs For Radiopharmaceuticals; Congress Blocks Rate Cap

CMS is willing to consider switching Medicare Part B payment for radiopharmaceuticals to the average sales price formula, the agency says in proposed rules to update Medicare's hospital outpatient prospective payment system for 2009

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts